title: Tamoxifen induced-thrombocytopenia: it does occur.
abstract: Tamoxifen has been in the center of management of hormone-sensitive breast cancer. Furthermore, it represents the best example of chemo-prevention: It reduces the incidence of invasive breast cancer. However, it has some side effects, several of them are severe. Oncologists, hematologists, internal medicine specialists and gynecologists must know this agent in detail. Authors report a very rare side effect, thrombocytopenia, and discuss it briefly.
authors.affiliation: Dahiliye Klinigi, Ankara Numune Hastanesi, Ankara, Turkey.
authors.forename: Narin
authors.initials: N
authors.lastname: Nasiroğlu
authors.forename: Merve
authors.initials: M
authors.lastname: Pamukçuoğlu
authors.forename: Hüseyin
authors.initials: H
authors.lastname: Abali
authors.forename: Berna
authors.initials: B
authors.lastname: Oksüzoğlu
authors.forename: Ayşegül
authors.initials: A
authors.lastname: Uner
authors.forename: Nurullah
authors.initials: N
authors.lastname: Zengin
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects* / Q000627:therapeutic use; D001853:Bone Marrow / Q000473:pathology; D001943:Breast Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000601:surgery; D044584:Carcinoma, Ductal / Q000175:diagnosis / Q000188:drug therapy* / Q000601:surgery; D005260:Female; D006801:Humans; D008875:Middle Aged; D013629:Tamoxifen / Q000009:adverse effects* / Q000627:therapeutic use; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000175:diagnosis*; D028761:Withholding Treatment
chemical_list: D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen